(Q39531701)

12 September 2017

title

Mutational analysis of VACM-1/cul5 exons in cancer cell lines (English)

1 reference

Maria A Burnatowska-Hledin

12 September 2017

1 reference

5

object named as

Maria A Burnatowska-Hledin

1 reference

12 September 2017

Steven P Lewis

1

1 reference

12 September 2017

Angelica N Willis

2

1 reference

12 September 2017

Alyssa E Johnson

3

1 reference

12 September 2017

James Resau

4

1 reference

12 September 2017

publication date

1 July 2011

1 reference

Acta Pathologica et Microbiologica Scandinavica

12 September 2017

published in

1 reference

12 September 2017

volume

119

1 reference

12 September 2017

issue

7

1 reference

12 September 2017

page(s)

421-430

1 reference

Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Covalent modification of all members of human cullin family proteins by NEDD8

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Neddylation and deneddylation of CUL-3 is required to target MEI-1/Katanin for degradation at the meiosis-to-mitosis transition in C. elegans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

A novel nonsense mutation in CUL4B gene in three brothers with X-linked mental retardation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Role of VHL gene mutation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Mutational analysis of hypoxia-related genes HIF1alpha and CUL2 in common human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Mutations in Cullin 4B result in a human syndrome associated with increased camptothecin-induced topoisomerase I-dependent DNA breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Estrogen-dependent growth and estrogen receptor (ER)-alpha concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Resveratrol enhances anti-proliferative effect of VACM-1/cul5 in T47D cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Restriction of Src activity by Cullin-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Phosphorylation of VACM-1/Cul5 by protein kinase A regulates its neddylation and antiproliferative effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Regulation of cullin-RING E3 ubiquitin-ligases by neddylation and dimerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Expression of VACM-1 protein in cultured rat adrenal endothelial cells is linked to the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Expression of VACM-1/cul5 mutant in endothelial cells induces MAPK phosphorylation and maspin degradation and converts cells to the angiogenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

The Cullin3 ubiquitin ligase functions as a Nedd8-bound heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02747.X

10.1111/J.1600-0463.2011.02747.X

21 January 2018

Identifiers

DOI

1 reference

release_m3jahiqgnrgnvebcwirxdt4ski

12 September 2017

Fatcat ID

0 references

1 reference